Lack of effectiveness of combined 5-fluorouracil and methyl-ccnu therapy in advanced colorectal cancer (Q67040768)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:589555%20AND%20SRC:MED&resulttype=core&format=json

2 September 2019

title

Lack of effectiveness of combined 5- fluorouracil and methyl-CCNU therapy in advanced colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:589555%20AND%20SRC:MED&resulttype=core&format=json

2 September 2019

Lack of effectiveness of combined 5-fluorouracil and methyl-ccnu therapy in advanced colorectal cancer (English)

1 reference

10.1002/1097-0142(197712)40:6<2792::AID-CNCR2820400606>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2792::AID-CNCR2820400606%3E3.0.CO;2-R

25 July 2023

1 reference

1 reference

1 reference

1 reference

10.1002/1097-0142(197712)40:6<2792::AID-CNCR2820400606>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2792::AID-CNCR2820400606%3E3.0.CO;2-R

25 July 2023

author name string

J. J. Lokich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A589555

13 July 2022

A. T. Skarin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A589555

13 July 2022

R. J. Mayer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A589555

13 July 2022

E. Frei

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A589555

13 July 2022

language of work or name

English

0 references

publication date

1 December 1977

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:589555%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

2 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197712)40:6%3C2792::AID-CNCR2820400606%3E3.0.CO;2-R

1 reference

10.1002/1097-0142(197712)40:6<2792::AID-CNCR2820400606>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2792::AID-CNCR2820400606%3E3.0.CO;2-R

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197712)40:6%3C2792::AID-CNCR2820400606%3E3.0.CO;2-R

25 July 2023

1 reference

10.1002/1097-0142(197712)40:6<2792::AID-CNCR2820400606>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2792::AID-CNCR2820400606%3E3.0.CO;2-R

25 July 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:589555%20AND%20SRC:MED&resulttype=core&format=json

2 September 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:589555%20AND%20SRC:MED&resulttype=core&format=json

2 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:589555%20AND%20SRC:MED&resulttype=core&format=json

2 September 2019

page(s)

2792-2796

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:589555%20AND%20SRC:MED&resulttype=core&format=json

Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study

2 September 2019

cites work

1

1 reference

10.1002/1097-0142(197712)40:6<2792::AID-CNCR2820400606>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2792::AID-CNCR2820400606%3E3.0.CO;2-R

Fluorouracil, methyl-CCNU and vincristine in cancer of the colon

25 July 2023

4

1 reference

10.1002/1097-0142(197712)40:6<2792::AID-CNCR2820400606>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2792::AID-CNCR2820400606%3E3.0.CO;2-R

CEA Monitoring of Palliative Treatment for Colorectal Carcinoma

25 July 2023

6

1 reference

10.1002/1097-0142(197712)40:6<2792::AID-CNCR2820400606>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2792::AID-CNCR2820400606%3E3.0.CO;2-R

Combined 5-Fluorouracil and Hydroxyurea Therapy for Gastrointestinal Cancer

25 July 2023

8

1 reference

10.1002/1097-0142(197712)40:6<2792::AID-CNCR2820400606>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2792::AID-CNCR2820400606%3E3.0.CO;2-R

Brief Communication: Therapy of Advanced Colorectal Cancer With a Combination of 5-Flourouracil, Methyl-l,3-cis(2-chlorethyl)-1-nitrosourea, and Vincristine2

25 July 2023

11

1 reference

10.1002/1097-0142(197712)40:6<2792::AID-CNCR2820400606>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2792::AID-CNCR2820400606%3E3.0.CO;2-R

5-Fluorouracil with cytosine arabinoside in metastatic gastrointestinal cancer

25 July 2023

13

1 reference

10.1002/1097-0142(197712)40:6<2792::AID-CNCR2820400606>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2792::AID-CNCR2820400606%3E3.0.CO;2-R

Usefulness of serial serum carcinoembryonic antigen (CEA) determinations during anticancer therapy or long-term follow-up of gastrointestinal carcinoma

25 July 2023

14

1 reference

10.1002/1097-0142(197712)40:6<2792::AID-CNCR2820400606>3.0.CO;2-R

https://api.crossref.org/works/10.1002/1097-0142(197712)40:6%3C2792::AID-CNCR2820400606%3E3.0.CO;2-R

25 July 2023

Identifiers

10.1002/1097-0142(197712)40:6<2792::AID-CNCR2820400606>3.0.CO;2-R

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:589555%20AND%20SRC:MED&resulttype=core&format=json

2 September 2019

1 reference